GLP-1s like Ozempic and Wegovy are gaining popularity in the healthcare industry with over 9 million prescriptions written in the last three months. These drugs are effective in weight loss, but long-term side effects remain unknown. Concerns include high discontinuation rates due to side effects and the need for lifestyle changes to sustain weight loss once off the medication. Payers need to consider additional programs to address these challenges. Lifestyle modifications, exercise, and social support are important alongside GLP-1 therapy for sustainable weight management. Payers can encourage a holistic approach by providing counseling and nutritional support to address social factors influencing weight management.
Source link
Are GLP-1 Drugs Here to Stay?
